4109 加捷生醫歷年利潤比率
| 年度/季別 | 毛利率 | 營業利益率 | 稅前淨利率 | 稅後淨利率 |
|---|
| 2025Q2 | 35.84% | 3.73% | 7.13% | 0.17% |
| 2025Q1 | 36.01% | 8.08% | 16.35% | 10.73% |
| 2024Q4 | 32.72% | 8.12% | -12.52% | -13.27% |
| 2024Q3 | 32.41% | -0.71% | 4.88% | 4.19% |
| 2024Q2 | 32.24% | 4.55% | 144.96% | 142.61% |
| 2024Q1 | 31.87% | 10.23% | 11.23% | 8.65% |
| 2023Q4 | 23.91% | -30.55% | 187.05% | 190.96% |
| 2023Q3 | 41.72% | -1.12% | 25.88% | 24.04% |
| 2023Q2 | 35.03% | -18.35% | -12.90% | -13.57% |
| 2023Q1 | 41.32% | -29.98% | -27.91% | -28.82% |
| 2022Q4 | 37.25% | -5.06% | -1.77% | -1.85% |
| 2022Q3 | 36.89% | -0.10% | 2.63% | 1.27% |
| 2022Q2 | 36.14% | -9.34% | -4.97% | -5.80% |
| 2022Q1 | 36.24% | -3.58% | -2.54% | -2.49% |
| 2021Q4 | 36.83% | 7.24% | 10.13% | 9.90% |
| 2021Q3 | 32.60% | -5.28% | 0.88% | 0.88% |
| 2021Q2 | 36.83% | -1.40% | 0.42% | -0.86% |
| 2021Q1 | 30.93% | -5.94% | -6.85% | -5.64% |
| 2020Q4 | 16.43% | -16.87% | -16.03% | -12.85% |
| 2020Q3 | 35.01% | -4.03% | 4.45% | 9.24% |
| 2020Q2 | -13.93% | -46.00% | -45.17% | -38.39% |